Tags

Type your tag names separated by a space and hit enter

Cavernous sinus meningioma.
Handb Clin Neurol. 2020; 170:69-85.HC

Abstract

Cavernous sinus meningioma (CSM) presents a management challenge to present-day neurosurgeons. Lack of adequate understanding of the natural history of these lesions, the early involvement of vital neurovascular structures, the absence of clear tissue planes with normal surrounding structures, and a high rate of aggressive surgery-related morbidity each pose management dilemmas for neurosurgeons. Over the past few decades, the enthusiasm of the neurosurgical community has shifted from aggressive microsurgical resection to maximal safe resection and institution of adjuvant radiotherapy, if necessary. This paradigm shift has ensured better functional outcome in treated patients. This chapter has been designed to discuss the current treatment algorithm and the importance of multimodality management for optimal outcome in patients with CSM. The technical aspects of this approach to management are presented, and the various treatment options are compared.

Authors+Show Affiliations

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, United States.Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, United States. Electronic address: william.couldwell@hsc.utah.edu.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32586510

Citation

Raheja, Amol, and William T. Couldwell. "Cavernous Sinus Meningioma." Handbook of Clinical Neurology, vol. 170, 2020, pp. 69-85.
Raheja A, Couldwell WT. Cavernous sinus meningioma. Handb Clin Neurol. 2020;170:69-85.
Raheja, A., & Couldwell, W. T. (2020). Cavernous sinus meningioma. Handbook of Clinical Neurology, 170, 69-85. https://doi.org/10.1016/B978-0-12-822198-3.00029-X
Raheja A, Couldwell WT. Cavernous Sinus Meningioma. Handb Clin Neurol. 2020;170:69-85. PubMed PMID: 32586510.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cavernous sinus meningioma. AU - Raheja,Amol, AU - Couldwell,William T, PY - 2020/6/27/entrez KW - Cavernous sinus KW - Fractionated stereotactic radiation therapy KW - Meningioma KW - Multimodality management KW - Skull base KW - Stereotactic radiosurgery KW - Surgery KW - Treatment algorithm KW - Tumor SP - 69 EP - 85 JF - Handbook of clinical neurology JO - Handb Clin Neurol VL - 170 N2 - Cavernous sinus meningioma (CSM) presents a management challenge to present-day neurosurgeons. Lack of adequate understanding of the natural history of these lesions, the early involvement of vital neurovascular structures, the absence of clear tissue planes with normal surrounding structures, and a high rate of aggressive surgery-related morbidity each pose management dilemmas for neurosurgeons. Over the past few decades, the enthusiasm of the neurosurgical community has shifted from aggressive microsurgical resection to maximal safe resection and institution of adjuvant radiotherapy, if necessary. This paradigm shift has ensured better functional outcome in treated patients. This chapter has been designed to discuss the current treatment algorithm and the importance of multimodality management for optimal outcome in patients with CSM. The technical aspects of this approach to management are presented, and the various treatment options are compared. SN - 0072-9752 UR - https://www.unboundmedicine.com/medline/citation/32586510/Cavernous_sinus_meningioma L2 - https://linkinghub.elsevier.com/retrieve/pii/B978-0-12-822198-3.00029-X DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.